FDA Warning Letter — Resonance Laboratories Private Limited
The FDA took a Warning Letter action against Resonance Laboratories Private Limited on February 3, 2017 (Doddaballapur, India). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Resonance Laboratories Private Limited
- Date
- February 3, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Doddaballapur (India)